주식/증권
📈 긍정적
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
요약
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.